220 related articles for article (PubMed ID: 34140410)
1. The effect of parathyroid hormone on osteogenesis is mediated partly by osteolectin.
Zhang J; Cohen A; Shen B; Du L; Tasdogan A; Zhao Z; Shane EJ; Morrison SJ
Proc Natl Acad Sci U S A; 2021 Jun; 118(25):. PubMed ID: 34140410
[TBL] [Abstract][Full Text] [Related]
2. Integrin alpha11 is an Osteolectin receptor and is required for the maintenance of adult skeletal bone mass.
Shen B; Vardy K; Hughes P; Tasdogan A; Zhao Z; Yue R; Crane GM; Morrison SJ
Elife; 2019 Jan; 8():. PubMed ID: 30632962
[TBL] [Abstract][Full Text] [Related]
3. Clec11a/osteolectin is an osteogenic growth factor that promotes the maintenance of the adult skeleton.
Yue R; Shen B; Morrison SJ
Elife; 2016 Dec; 5():. PubMed ID: 27976999
[TBL] [Abstract][Full Text] [Related]
4. A mechanosensitive peri-arteriolar niche for osteogenesis and lymphopoiesis.
Shen B; Tasdogan A; Ubellacker JM; Zhang J; Nosyreva ED; Du L; Murphy MM; Hu S; Yi Y; Kara N; Liu X; Guela S; Jia Y; Ramesh V; Embree C; Mitchell EC; Zhao YC; Ju LA; Hu Z; Crane GM; Zhao Z; Syeda R; Morrison SJ
Nature; 2021 Mar; 591(7850):438-444. PubMed ID: 33627868
[TBL] [Abstract][Full Text] [Related]
5. Osteolectin increases bone elongation and body length by promoting growth plate chondrocyte proliferation.
Zhang J; Du L; Davis B; Gu Z; Lyu J; Zhao Z; Xu J; Morrison SJ
Proc Natl Acad Sci U S A; 2023 May; 120(22):e2220159120. PubMed ID: 37216542
[TBL] [Abstract][Full Text] [Related]
6. Identification of Fibroblast Activation Protein as an Osteogenic Suppressor and Anti-osteoporosis Drug Target.
Wei H; Xu Y; Wang Y; Xu L; Mo C; Li L; Shen B; Sun Y; Cheng P; Yang L; Pang Y; Qin A; Cao Y; Morrison SJ; Yue R
Cell Rep; 2020 Oct; 33(2):108252. PubMed ID: 33053358
[TBL] [Abstract][Full Text] [Related]
7. Resorption controls bone anabolism driven by parathyroid hormone (PTH) receptor signaling in osteocytes.
Rhee Y; Lee EY; Lezcano V; Ronda AC; Condon KW; Allen MR; Plotkin LI; Bellido T
J Biol Chem; 2013 Oct; 288(41):29809-20. PubMed ID: 23963454
[TBL] [Abstract][Full Text] [Related]
8. The Deletion of Hdac4 in Mouse Osteoblasts Influences Both Catabolic and Anabolic Effects in Bone.
Nakatani T; Chen T; Johnson J; Westendorf JJ; Partridge NC
J Bone Miner Res; 2018 Jul; 33(7):1362-1375. PubMed ID: 29544022
[TBL] [Abstract][Full Text] [Related]
9. Role of fibroblast growth factor 2 and Wnt signaling in anabolic effects of parathyroid hormone on bone formation.
Fei Y; Hurley MM
J Cell Physiol; 2012 Nov; 227(11):3539-45. PubMed ID: 22378151
[TBL] [Abstract][Full Text] [Related]
10. The soluble interleukin-6 receptor is a mediator of hematopoietic and skeletal actions of parathyroid hormone.
Cho SW; Pirih FQ; Koh AJ; Michalski M; Eber MR; Ritchie K; Sinder B; Oh S; Al-Dujaili SA; Lee J; Kozloff K; Danciu T; Wronski TJ; McCauley LK
J Biol Chem; 2013 Mar; 288(10):6814-25. PubMed ID: 23297399
[TBL] [Abstract][Full Text] [Related]
11. Gender differences in the response of CD-1 mouse bone to parathyroid hormone: potential role of IGF-I.
Wang Y; Sakata T; Elalieh HZ; Munson SJ; Burghardt A; Majumdar S; Halloran BP; Bikle DD
J Endocrinol; 2006 May; 189(2):279-87. PubMed ID: 16648295
[TBL] [Abstract][Full Text] [Related]
12. TG-interacting factor 1 (Tgif1)-deficiency attenuates bone remodeling and blunts the anabolic response to parathyroid hormone.
Saito H; Gasser A; Bolamperti S; Maeda M; Matthies L; Jähn K; Long CL; Schlüter H; Kwiatkowski M; Saini V; Pajevic PD; Bellido T; van Wijnen AJ; Mohammad KS; Guise TA; Taipaleenmäki H; Hesse E
Nat Commun; 2019 Mar; 10(1):1354. PubMed ID: 30902975
[TBL] [Abstract][Full Text] [Related]
13. Progenitor recruitment and adipogenic lipolysis contribute to the anabolic actions of parathyroid hormone on the skeleton.
Maridas DE; Rendina-Ruedy E; Helderman RC; DeMambro VE; Brooks D; Guntur AR; Lanske B; Bouxsein ML; Rosen CJ
FASEB J; 2019 Feb; 33(2):2885-2898. PubMed ID: 30354669
[TBL] [Abstract][Full Text] [Related]
14. Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain.
Yu C; Xuan M; Zhang M; Yao Q; Zhang K; Zhang X; Guo J; Song L
J Bone Miner Metab; 2018 Sep; 36(5):560-572. PubMed ID: 29124436
[TBL] [Abstract][Full Text] [Related]
15. Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies.
Esbrit P; Alcaraz MJ
Biochem Pharmacol; 2013 May; 85(10):1417-23. PubMed ID: 23500550
[TBL] [Abstract][Full Text] [Related]
16. Human umbilical cord mesenchymal stromal cells-derived extracellular vesicles exert potent bone protective effects by CLEC11A-mediated regulation of bone metabolism.
Hu Y; Zhang Y; Ni CY; Chen CY; Rao SS; Yin H; Huang J; Tan YJ; Wang ZX; Cao J; Liu ZZ; Xie PL; Wu B; Luo J; Xie H
Theranostics; 2020; 10(5):2293-2308. PubMed ID: 32089743
[TBL] [Abstract][Full Text] [Related]
17. [Hormones and osteoporosis update. Mechanisms of anabolic and catabolic effects of PTH on bone].
Kobayashi T
Clin Calcium; 2009 Jul; 19(7):911-8. PubMed ID: 19567985
[TBL] [Abstract][Full Text] [Related]
18. Control of Bone Anabolism in Response to Mechanical Loading and PTH by Distinct Mechanisms Downstream of the PTH Receptor.
Delgado-Calle J; Tu X; Pacheco-Costa R; McAndrews K; Edwards R; Pellegrini GG; Kuhlenschmidt K; Olivos N; Robling A; Peacock M; Plotkin LI; Bellido T
J Bone Miner Res; 2017 Mar; 32(3):522-535. PubMed ID: 27704638
[TBL] [Abstract][Full Text] [Related]
19. Aging periosteal progenitor cells have reduced regenerative responsiveness to bone injury and to the anabolic actions of PTH 1-34 treatment.
Yukata K; Xie C; Li TF; Takahata M; Hoak D; Kondabolu S; Zhang X; Awad HA; Schwarz EM; Beck CA; Jonason JH; O'Keefe RJ
Bone; 2014 May; 62():79-89. PubMed ID: 24530870
[TBL] [Abstract][Full Text] [Related]
20. The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics.
Lombardi G; Di Somma C; Rubino M; Faggiano A; Vuolo L; Guerra E; Contaldi P; Savastano S; Colao A
J Endocrinol Invest; 2011 Jul; 34(7 Suppl):18-22. PubMed ID: 21985975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]